Skip to main content
HLB Therapeutics Co.,Ltd. logo

HLB Therapeutics Co.,Ltd. — Investor Relations & Filings

Ticker · 115450 ISIN · KR7115450009 KO Manufacturing
Open in API
Filings indexed 444 across all filing types
Latest filing 2021-11-16 Declaration of Voting R…
Country KR South Korea
Listing KO 115450

About HLB Therapeutics Co.,Ltd.

https://hlbtherapeutics.co.kr/en/

HLB Therapeutics Co., Ltd. is a biopharmaceutical company specializing in the development of innovative, first-in-class drugs for rare and intractable diseases. The company's clinical-stage pipeline focuses on addressing unmet medical needs in ophthalmology and oncology. Key development programs include RGN-259, a therapeutic agent for Dry Eye Disease and Neurotrophic Keratopathy, and OKN-007 for the treatment of Glioblastoma Multiforme. Additionally, the company is advancing a Natural Killer (NK) cell therapy through late-stage clinical trials to provide new therapeutic options for patients.

Recent filings

Filing Released Lang Actions
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of an Extraordinary General Meeting (EGM) of shareholders for the company 'GtreeBNT'. It details the voting outcomes for various agenda items, including the appointment of directors and auditors, and changes to the articles of incorporation. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2021-11-16 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details the appointment of new outside directors following an extraordinary general meeting. This falls under the category of Board/Management Information, specifically regarding changes in the board of directors.
2021-11-16 Korean
상호변경안내
Regulatory Filings Classification · 100% confidence The document is a short announcement regarding a change of company name (from G-treeBNT to HLB Therapeutics). It does not fit into specific financial reporting categories like 10-K or IR, nor is it a report publication announcement. As it is a corporate announcement regarding a fundamental change in company identity that does not fit other specific categories, it is classified as a general regulatory filing.
2021-11-16 Korean
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the change of the company's CEO (Representative Director). It details the outgoing and incoming directors, the reason for the change, the date of the board resolution, and the background of the new appointee. This falls directly under the category of board or management changes.
2021-11-16 Korean
증권발행결과(자율공시)(제13회차 CB)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '증권 발행결과' (Securities Issuance Result) regarding the issuance of convertible bonds (CB). It details the issuance method, amount, and payment date. This falls under capital financing activities, specifically related to the issuance of debt instruments that can be converted into equity, which is best categorized as a Capital/Financing Update (CAP).
2021-11-16 Korean
증권발행결과(자율공시)
Capital/Financing Update Classification · 100% confidence The document is a formal announcement regarding the 'Results of Securities Issuance' (증권 발행결과) for convertible bonds (전환사채). It details the issuance amount, payment date, and method, which falls under capital structure changes and financing activities. According to the provided definitions, this is a Capital/Financing Update.
2021-11-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.